Tenaya Therapeutics Inc (TNYA) Stock Price

1.43 ▲ +0.15 (+11.72%)
Open: 1.20 Vol: 6.44M Day's range: 1.20 - 1.475 Nov 10, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TNYA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL BUY BUY NEUTRAL NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.45▼ 1.43▲ 1.40▲ 1.36▲ 1.52▼
MA10 1.45▼ 1.37▲ 1.34▲ 1.39▲ 1.56▼
MA20 1.43▼ 1.33▲ 1.34▲ 1.60▼ 1.24▲
MA50 1.36▲ 1.35▲ 1.37▲ 1.53▼ 1.08▲
MA100 1.32▲ 1.37▲ 1.48▼ 1.17▲ 2.34▼
MA200 1.34▲ 1.52▼ 1.67▼ 0.91▲ 3.73▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ 0.019▲ 0.020▲ -0.040▼ 0.022▲
RSI 54.275▲ 63.592▲ 61.452▲ 45.221▼ 53.720▲
STOCH 73.889     86.830▲ 80.719▲ 34.225     43.181    
WILL %R -61.538     -15.686▲ -15.686▲ -64.063     -54.277    
CCI -46.281     109.202▲ 160.230▲ -59.084     -21.174    
Latest Filters Detected On TNYA
MA $TNYA Price Crossed Above MA(7) Set Alert
▼ GAP $TNYA Open Gap Down %5 Set Alert
▼ GAP $TNYA Open Gap Down %3 Set Alert
▼ GAP $TNYA Open Gap Down %2 Set Alert
CDL $TNYA Engulfing Candlestick Pattern Detected Set Alert
Tenaya Therapeutics Inc News
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Monday, November 10, 2025 04:30 AM
Presentation of MyPEAK-1 Data and the American Heart Association Scientific Sessions Showed Consistent, Deeper, and Durable Improvement in Measures of Hypertrophy for Cohort 1 Patients Initial TN-201 ...
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated ...
Saturday, November 08, 2025 09:02 AM
MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovascular ...
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
Tuesday, November 04, 2025 02:57 PM
Oral Presentation on Saturday to Highlight Interim Safety and Efficacy Results from the MyPEAK™-1 Phase 1b/2a Clinical Trial in Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy Second ...
TNYA historical stock data
date open high low close volume
10/11/25 1.20 1.475 1.20 1.43 6,444,695
07/11/25 1.31 1.34 1.25 1.28 5,195,616
06/11/25 1.38 1.43 1.33 1.35 2,162,426
05/11/25 1.40 1.47 1.37 1.38 2,823,412
04/11/25 1.37 1.48 1.36 1.38 2,476,321
03/11/25 1.50 1.54 1.37 1.43 5,736,773
31/10/25 1.24 1.4797 1.24 1.44 5,157,041
30/10/25 1.37 1.4499 1.22 1.26 6,867,783
29/10/25 1.53 1.54 1.40 1.43 6,424,293
28/10/25 1.64 1.65 1.55 1.56 4,327,045
Quote Details
52wk Low:0.36
52wk High:4.01
Vol:6.44M
Avg Vol(3m):69.8M
1Y Chng:-51.69%
1M Chng:-11.73%
Add to Watch List
More Information
Index US Composite
Market Cap. 208.61M